|
시장보고서
상품코드
2039069
안드로겐성 탈모증 치료 시장 : 약제 유형별, 투여 경로별, 성별별, 판매 채널별, 지역별Androgenetic Alopecia Treatment Market, By Drug Type, By Route of Administration, By Gender, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
안드로겐성 탈모증 치료 시장은 2026년에 26억 2,000만 달러로 추정되고 있으며, 2033년까지 45억 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 8.4%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 26억 2,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 8.40% | 2033년 시장 규모 예측 : | 45억 달러 |
안드로겐성 탈모증은 서서히 진행되는 탈모증의 일종으로 사춘기 시작 후 발병합니다. 미국 국립생물공학정보센터(NCBI)에 따르면 안드로겐성 탈모증은 안드로겐에 대한 과도한 반응으로 인해 유전적으로 결정되는 질환으로, 전 세계 남성과 여성의 최대 50%가 영향을 받고 있습니다. 이 질환은 남성과 여성 모두에서 특징적인 분포를 보이는 두피의 종모(終毛)의 점진적인 손실이 특징입니다. 남성의 경우 탈모는 정수리 및 전두 측두부에서 가장 두드러지게 나타나며, 여성의 경우 정수리 헤어라인은 보통 유지되고 정수리 모발이 광범위하게 얇아지는 이른바 '전두부가 넓어지는' 유형의 탈모가 나타납니다.
시장 역학
안드로겐성 탈모증 발병률의 증가는 글로벌 안드로겐성 탈모증 치료 시장의 성장을 촉진할 것으로 예상됩니다. 미국 국립보건원(NIH) 산하 의학도서관인 미국 국립의학도서관(NLM)에 따르면 미국에서는 약 5,000만 명의 남성과 3,000만 명의 여성이 안드로겐성 탈모증을 앓고 있다고 합니다.
그러나 대체 치료의 존재가 시장 성장을 저해할 것으로 예상됩니다. 예를 들어 두피 축소술과 같은 모발 재생 수술은 자주 시행되지 않지만, 모발 이식의 효과는 기증자 우위 원칙에 기반하고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신약 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서는 회사 개요, 재무 실적, 제품 포트폴리오, 시장 점유율, 유통 전략, 주요 개발, 전략 및 향후 계획과 같은 매개 변수를 기반으로 세계의 안드로겐성 탈모증 치료제 시장의 주요 업체를 분석합니다.
- 이 보고서의 분석 결과를 통해 기업의 마케팅 담당자와 경영진은 향후 의약품 출시, 약제 클래스 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 세계의 안드로겐성 탈모증 치료 시장 보고서는 투자자, 공급업체, 제조업체, 유통업체, 신규 진입자, 금융 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 안드로겐성 탈모증 치료제 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 개요
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 안드로겐성 탈모증 치료 시장 : 약제 유형별, 2021-2033년
제5장 세계의 안드로겐성 탈모증 치료 시장 : 투여 경로별, 2021-2033년
제6장 세계의 안드로겐성 탈모증 치료 시장 : 성별, 2021-2033년
제7장 세계의 안드로겐성 탈모증 치료 시장 : 유통 채널별, 2021-2033년
제8장 세계의 안드로겐성 탈모증 치료 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 추천
제11장 참고 문헌 및 조사 방법
KSA 26.06.02Androgenetic Alopecia Treatment Market is estimated to be valued at USD 2.62 Bn in 2026 and is expected to reach USD 4.5 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.62 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.40% | 2033 Value Projection: | USD 4.5 Bn |
Androgenetic alopecia, a slow progressive form of alopecia, begins after the onset of puberty. Pattern or androgenetic alopecia is a genetically predetermined disorder due to excessive response to androgens that affects up to 50% of males and females globally, according to the National Center for Biotechnology Information (NCBI). It is characterized by progressive loss of terminal hair of the scalp, in a characteristic distribution in both males and females. In males, hair loss is most prominent in the vertex and frontotemporal regions, while in women the frontal hairline is typically spared with diffuse apical hair loss noted as a wider anterior part of the hair.
Market Dynamics
Rising incidence of androgenetic alopecia is expected to drive the global androgenetic alopecia treatment market growth. According to the National Library of Medicine (NLM), a medical library which is part of the National Institutes of Health (NIH), androgenetic alopecia affects approximately 50 million men and 30 million women in the U.S.
However, availability of alternative treatments is expected to hinder the market growth. For instance, hair restoration surgery such as scalp reduction surgeries, which is not used frequently but efficacy of hair transplantation is based on the principle of donor dominance.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global androgenetic alopecia treatment market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study are Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy's Laboratories, HCell Inc., Follica, Inc. and Ranbaxy Laboratories Ltd. among others
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
- The global androgenetic alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global androgenetic alopecia treatment market.
Market Segmentation
- By Drug Type (Revenue, USD Bn, 2021-2033)
- Topical Agents
- 5 AR Inhibitors
- Others
- By Route of Administration (Revenue, USD Bn, 2021-2033)
- Oral
- Topical
- By Gender (Revenue, USD Bn, 2021-2033)
- Male
- Female
- By Distribution Channel (Revenue, USD Bn, 2021-2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Histogen Inc.
- Cipla Limited
- Aclaris Therapeutics, Inc.
- Merck & Co., Inc.
- Daiichi-Sankyo Co., Ltd.
- Johnson and Johnson Services, Inc.
- Lexington International LLC
- Vita-Cos-Med Klett-Loch GmbH
- PureTech
- Vitabiotics
- Reddy's Laboratories
- HCell Inc.
- Follica, Inc.
- Ranbaxy Laboratories Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Androgenetic Alopecia Treatment Market, By Drug Type
- Global Androgenetic Alopecia Treatment Market, By Route of Administration
- Global Androgenetic Alopecia Treatment Market, By Gender
- Global Androgenetic Alopecia Treatment Market, By Distribution Channel
- Global Androgenetic Alopecia Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend
4. Global Androgenetic Alopecia Treatment Market, By Drug Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Topical Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- 5 AR Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Androgenetic Alopecia Treatment Market, By Route of Administration, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Androgenetic Alopecia Treatment Market, By Gender, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Androgenetic Alopecia Treatment Market, By Distribution Channel, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Androgenetic Alopecia Treatment Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Histogen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cipla Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aclaris Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Daiichi-Sankyo Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lexington International LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vita-Cos-Med Klett-Loch GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PureTech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vitabiotics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dr. Reddy's Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HCell Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Follica, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ranbaxy Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
